Free Trial

Oxbridge Re (OXBR) Competitors

Oxbridge Re logo
$2.17 -0.10 (-4.41%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$2.15 -0.02 (-0.69%)
As of 07/3/2025 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OXBR vs. HIT, AAME, ZBAO, HUIZ, FGF, AIFU, CNFR, TIRX, UNAM, and XHG

Should you be buying Oxbridge Re stock or one of its competitors? The main competitors of Oxbridge Re include Health In Tech (HIT), Atlantic American (AAME), Zhibao Technology (ZBAO), Huize (HUIZ), Fundamental Global (FGF), AIFU (AIFU), Conifer (CNFR), Tian Ruixiang (TIRX), Unico American (UNAM), and XChange TEC.INC. (XHG). These companies are all part of the "insurance" industry.

Oxbridge Re vs. Its Competitors

Oxbridge Re (NASDAQ:OXBR) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment.

Health In Tech has a net margin of 0.00% compared to Oxbridge Re's net margin of -143.80%. Health In Tech's return on equity of 0.00% beat Oxbridge Re's return on equity.

Company Net Margins Return on Equity Return on Assets
Oxbridge Re-143.80% -41.78% -23.85%
Health In Tech N/A N/A N/A

Oxbridge Re currently has a consensus target price of $5.00, indicating a potential upside of 130.41%. Health In Tech has a consensus target price of $2.50, indicating a potential upside of 193.81%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than Oxbridge Re.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oxbridge Re
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Health In Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

5.6% of Oxbridge Re shares are owned by institutional investors. 19.5% of Oxbridge Re shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Health In Tech has higher revenue and earnings than Oxbridge Re.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxbridge Re$550K29.35-$2.73M-$0.30-7.23
Health In Tech$22.38M2.08N/AN/AN/A

In the previous week, Health In Tech had 1 more articles in the media than Oxbridge Re. MarketBeat recorded 2 mentions for Health In Tech and 1 mentions for Oxbridge Re. Health In Tech's average media sentiment score of 0.34 beat Oxbridge Re's score of 0.00 indicating that Health In Tech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oxbridge Re
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Health In Tech
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Health In Tech beats Oxbridge Re on 9 of the 13 factors compared between the two stocks.

Get Oxbridge Re News Delivered to You Automatically

Sign up to receive the latest news and ratings for OXBR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OXBR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OXBR vs. The Competition

MetricOxbridge ReINS IndustryFinance SectorNASDAQ Exchange
Market Cap$16.90M$26.65B$12.04B$8.95B
Dividend YieldN/A1.12%5.57%4.08%
P/E Ratio-7.2337.8520.0720.04
Price / Sales29.354.9225.60118.51
Price / CashN/A34.0721.5057.47
Price / Book3.194.972.285.67
Net Income-$2.73M$835.90M$1.00B$248.47M
7 Day Performance24.00%1.12%2.19%3.32%
1 Month Performance41.83%1.77%4.44%5.20%
1 Year Performance-2.69%3.42%540.82%21.35%

Oxbridge Re Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OXBR
Oxbridge Re
2.5964 of 5 stars
$2.17
-4.4%
$5.00
+130.4%
-6.5%$16.90M$550K-7.233Gap Down
High Trading Volume
HIT
Health In Tech
N/A$0.88
+6.4%
$2.50
+184.1%
N/A$48.11M$22.38M0.0079Gap Up
AAME
Atlantic American
0.4097 of 5 stars
$2.13
+4.4%
N/A+46.8%$41.61M$188.23M-23.66140News Coverage
ZBAO
Zhibao Technology
N/A$1.01
-1.0%
N/A-75.3%$32.15M$25.27M0.00148News Coverage
Positive News
Gap Down
HUIZ
Huize
1.404 of 5 stars
$2.10
+0.5%
$2.30
+9.5%
-91.9%$21.08M$171.10M-5.001,640
FGF
Fundamental Global
1.2239 of 5 stars
$16.00
-0.1%
N/A-31.4%$20.37M$17.35M12.219News Coverage
Gap Up
AIFU
AIFU
N/A$6.04
+3.4%
N/AN/A$16.91M$247.81M8.274,707Gap Up
CNFR
Conifer
N/A$0.73
-8.1%
N/A-10.6%$9.65M$67.27M0.37150Positive News
TIRX
Tian Ruixiang
0.821 of 5 stars
$1.18
-4.1%
N/A-44.6%$890K$3.22M0.0050News Coverage
Positive News
UNAM
Unico American
N/A$0.07
-13.7%
N/AN/A$430KN/A0.0040Gap Down
High Trading Volume
XHG
XChange TEC.INC.
N/A$1.28
-6.6%
N/AN/A$20K$41.09M0.0030Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:OXBR) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners